MSF at the Okinawa G8
MSF believes that prevention and treatment are both essential and complementary components of any strategy for fighting a disease. The G8 should support a global system of equity pricing to make key medicines affordable to the developing world. Prices should be reduced by at least 20-100 times the current prices - in keeping with the pricing strategies applied to vaccines.
The market has failed - and will continue to fail - to stimulate enough R&D for medicines for the diseases of the poor. Increasing R&D for priority global diseases - such as TB and tropical diseases - cannot happen without government commitment and intervention. Public funds should be allocated to support drug research.